Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Oligonucleotide Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oligonucleotide Therapeuticsmarket, defines the market attractiveness level of Oligonucleotide Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oligonucleotide Therapeutics industry, describes the types of Oligonucleotide Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oligonucleotide Therapeutics market and the development prospects and opportunities of Oligonucleotide Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oligonucleotide Therapeutics market in Chapter 13.
By Player:
Arrowhead Pharmaceuticals
GlaxoSmithKline
Ionis Pharmaceuticals
miRagen Therapeutics
Biogen
By Type:
Antisense/RNAi oligonucleotides
Others
By End-User:
Neurological disorders
Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oligonucleotide Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oligonucleotide Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oligonucleotide Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oligonucleotide Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oligonucleotide Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Oligonucleotide Therapeutics Consumption (2017-2022)
-
7.2 United States Oligonucleotide Therapeutics Consumption (2017-2022)
-
7.3 Europe Oligonucleotide Therapeutics Consumption (2017-2022)
-
7.4 China Oligonucleotide Therapeutics Consumption (2017-2022)
-
7.5 Japan Oligonucleotide Therapeutics Consumption (2017-2022)
-
7.6 India Oligonucleotide Therapeutics Consumption (2017-2022)
-
7.7 South Korea Oligonucleotide Therapeutics Consumption (2017-2022)
8 Region and Country-wise Oligonucleotide Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Oligonucleotide Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Oligonucleotide Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Oligonucleotide Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Oligonucleotide Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Oligonucleotide Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Oligonucleotide Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Oligonucleotide Therapeutics Consumption Forecast (2022-2028)
9 Global Oligonucleotide Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Oligonucleotide Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antisense/RNAi oligonucleotides Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Oligonucleotide Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Neurological disorders Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Oligonucleotide Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Oligonucleotide Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antisense/RNAi oligonucleotides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oligonucleotide Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Neurological disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Oligonucleotide Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oligonucleotide Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oligonucleotide Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oligonucleotide Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oligonucleotide Therapeutics Market Competitive Analysis
-
14.1 Arrowhead Pharmaceuticals
-
14.1.1 Arrowhead Pharmaceuticals Company Details
-
14.1.2 Arrowhead Pharmaceuticals Oligonucleotide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Arrowhead Pharmaceuticals Oligonucleotide Therapeutics Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Oligonucleotide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Oligonucleotide Therapeutics Product and Service
-
14.3 Ionis Pharmaceuticals
-
14.3.1 Ionis Pharmaceuticals Company Details
-
14.3.2 Ionis Pharmaceuticals Oligonucleotide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Ionis Pharmaceuticals Oligonucleotide Therapeutics Product and Service
-
14.4 miRagen Therapeutics
-
14.4.1 miRagen Therapeutics Company Details
-
14.4.2 miRagen Therapeutics Oligonucleotide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 miRagen Therapeutics Oligonucleotide Therapeutics Product and Service
-
14.5 Biogen
-
14.5.1 Biogen Company Details
-
14.5.2 Biogen Oligonucleotide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biogen Oligonucleotide Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oligonucleotide Therapeutics
-
Figure Oligonucleotide Therapeutics Picture
-
Table Global Oligonucleotide Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oligonucleotide Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oligonucleotide Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oligonucleotide Therapeutics Consumption by Country (2017-2022)
-
Figure United States Oligonucleotide Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Oligonucleotide Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Oligonucleotide Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Oligonucleotide Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Oligonucleotide Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oligonucleotide Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Oligonucleotide Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Oligonucleotide Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oligonucleotide Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oligonucleotide Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oligonucleotide Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oligonucleotide Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oligonucleotide Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antisense/RNAi oligonucleotides Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Antisense/RNAi oligonucleotides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurological disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oligonucleotide Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oligonucleotide Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Arrowhead Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Arrowhead Pharmaceuticals Oligonucleotide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arrowhead Pharmaceuticals Oligonucleotide Therapeutics Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Oligonucleotide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Oligonucleotide Therapeutics Product and Service
-
Table Ionis Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Ionis Pharmaceuticals Oligonucleotide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ionis Pharmaceuticals Oligonucleotide Therapeutics Product and Service
-
Table miRagen Therapeutics (Foundation Year, Company Profile and etc.)
-
Table miRagen Therapeutics Oligonucleotide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table miRagen Therapeutics Oligonucleotide Therapeutics Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Oligonucleotide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Oligonucleotide Therapeutics Product and Service
-
